Retour

Healthcare Market Research: Methods, Rules and Examples

Matthieu Saussaye

Healthcare market research is the study of how patients, healthcare professionals (HCPs), payers and providers make decisions about treatments, devices and care services. It uses the same tools as any market research, surveys, interviews, conjoint and tracking, but under tighter constraints: small and hard-to-reach professional samples, privacy law on health data, and, in pharma, an obligation to report adverse events that respondents mention.

What makes it different:

  • Four audiences, not one. The patient uses the product, the physician chooses it, the payer funds it, and the hospital or pharmacy buys it. Each needs its own study design.

  • Professional samples are small and expensive. There may be only a few hundred specialists of a given type in a country, and their time is paid at professional rates.

  • Health data is regulated. In the US, HIPAA governs identifiable health information held by covered entities; in Europe, GDPR treats health data as a special category.

  • Adverse events must be handled. Pharma-sponsored research typically requires interviewers and platforms to flag any mention of a side effect linked to the sponsor's product.

  • Wording carries clinical weight. Questions must be medically accurate for HCPs and plain-language for patients.

Who you research, and how

Most healthcare studies fail when they pick the method first. Pick the audience and decision first, then the method that fits that audience's constraints.

Audience

Decisions you study

Typical methods

Sample realities

Key constraint

Patients and caregivers

Symptom recognition, treatment adherence, channel and provider choice

Online surveys, diaries, patient journey interviews, community recruitment

Common conditions: panels work. Rare diseases: patient associations and snowball recruitment

Consent, plain language, sensitivity, vulnerable groups

Physicians and specialists

Prescribing, referral, device choice, unmet clinical needs

In-depth interviews, quantitative HCP surveys, conjoint, chart audits

Specialist universes can be in the hundreds; verified medical panels required

Fair-market-value honoraria, adverse event reporting, transparency rules

Nurses, pharmacists, allied health

Administration, substitution, patient education

Short surveys, workflow observation, interviews

Larger populations, often overlooked

Shift work: field over longer periods

Payers and market access

Formulary listing, reimbursement, value evidence

Advisory boards, in-depth interviews, value-proposition testing

Very small: sometimes a dozen decision makers per market

Confidentiality, policy sensitivity

Providers and administrators

Procurement, service lines, patient experience

B2B interviews, satisfaction and experience surveys

Hospital and clinic decision makers

Procurement cycles, committee decisions

A launch study for a new therapy typically touches at least three rows: physicians for positioning, patients for the journey and adherence barriers, and payers for access.

The core healthcare research studies

Patient journey mapping

Maps every step from first symptom to diagnosis, treatment, switching and long-term management. It shows where patients drop out, wait, or lose trust. Interviews with 20 to 40 patients across stages usually reveal the main barriers; a quantitative survey then sizes how common each barrier is.

Awareness, trial and usage (ATU) tracking

The pharma and medtech equivalent of a brand tracker. Repeated HCP surveys measure unaided and aided awareness, trial, current use, prescribing share and intent to prescribe. Run a baseline before launch and repeat at fixed intervals with the same screener and questions, or the trend means nothing.

Message and concept testing

Tests claims, visual aids and positioning statements with HCPs before they reach sales teams. Each message is rated on believability, relevance and differentiation, and respondents explain in their own words what the claim means to them. Misreadings found here are far cheaper than misreadings found in the field. See our guide to concept testing for test design.

Conjoint on treatment attributes

Physicians and patients trade off efficacy, side-effect profile, dosing frequency, administration route and cost. Conjoint quantifies how much each attribute moves choice, which feeds demand forecasting and target product profiles.

Unmet needs and KOL interviews

Key opinion leaders and experienced specialists describe where current treatment falls short. These are qualitative, small-sample studies. Treat them as hypothesis generators and validate with a broader HCP sample, because KOLs often practice differently from the average physician.

Patient experience research for providers

Hospitals and clinics research access, waiting times, communication and discharge. In the US, hospitals already collect the standardized HCAHPS patient experience survey; custom research is most useful for the "why" behind those scores and for services HCAHPS does not cover.

Regulatory and ethical constraints

This is where generic market research guides stop and healthcare studies actually go wrong.

Health data privacy

In the US, the HIPAA Privacy Rule covers identifiable health information held by covered entities (health plans, clearinghouses and most providers) and their business associates. If you work with a provider's patient list, the data are in scope. The rule defines two routes to de-identification: an expert determination that re-identification risk is very small, or the "safe harbor" removal of listed identifiers, which include names and all geographic subdivisions smaller than a state, with only the first three digits of a ZIP code allowed under conditions (45 CFR 164.514).

For surveys this means: do not collect full ZIP codes, exact dates or free-text identifiers unless you have a lawful basis and a plan to protect them. In Europe, GDPR Article 9 treats health data as a special category that needs explicit consent or another specific condition.

Adverse event reporting

When a pharmaceutical company sponsors research, a respondent who mentions a side effect of the sponsor's product may trigger a pharmacovigilance reporting obligation. Industry codes for healthcare market research, such as those maintained by EphMRA in Europe and BHBIA in the UK, provide guidance on this. In practice:

  • Agree the reporting procedure and timelines with the sponsor before fieldwork.

  • Train interviewers and moderators to recognize a reportable event.

  • Add a consent line telling respondents that side-effect mentions may be reported, with their identity protected unless they agree otherwise.

  • Review open-ended text and transcripts for mentions, not only closed questions. AI coding can flag candidate passages, but a trained person should confirm.

Honoraria and transparency

HCP incentives should reflect fair market value for their time and should never be tied to prescribing. Some transparency regimes require sponsors to disclose payments to physicians; the usual safeguard in market research is a double-blind design where the agency knows the respondents, the sponsor does not, and respondents do not know the sponsor.

Vulnerable respondents

Patients with serious illness, minors and cognitively impaired respondents need extra care: shorter sessions, caregiver involvement, careful wording, and a way to stop at any time. Some studies need ethics review, especially if they edge toward clinical or academic research.

Example healthcare survey questions

Wording below is a starting point. Adapt clinical terms to the specialty, and pilot with two or three real respondents.

For physicians

  1. "In the last month, approximately how many patients with [condition] did you personally manage?" (screener and weighting)

  2. "Which treatments do you currently use as first-line therapy for [condition]? Select all that apply."

  3. "What is the main reason you would switch a stable patient to a different treatment?"

  4. "How satisfied are you with current treatment options for [patient type], on a scale from 1 (not at all) to 7 (completely)?"

  5. "Please rate this statement on believability and relevance: '[claim]'. In your own words, what does it mean for your patients?"

  6. "What, if anything, prevents you from prescribing [product class] more often?"

For patients and caregivers

  1. "How long was it between noticing your first symptoms and getting a diagnosis?"

  2. "Who did you speak to first about your symptoms?"

  3. "In the last two weeks, how often have you taken your treatment as prescribed?" (use neutral wording; adherence is prone to social desirability bias)

  4. "What is the hardest part of living with your treatment day to day?"

  5. "Where do you look for information about your condition?"

For payers and providers

  1. "What evidence would you need to see before adding [therapy] to the formulary?"

  2. "How do you compare the total cost of care between two treatment options?"

  3. "What would make a new service line worth investing in for your hospital?"

Healthcare research KPIs

KPI

Audience

Used for

Unaided / aided awareness

HCPs

Launch tracking, share of voice

Trial and current use

HCPs

Adoption curve after launch

Intent to prescribe

HCPs

Forecasting (always discount stated intent)

Message recall and believability

HCPs

Sales and medical communication effectiveness

Time to diagnosis

Patients

Patient journey, disease-awareness campaigns

Self-reported adherence

Patients

Support program design

Patient experience scores

Patients, providers

Service improvement, benchmarking against HCAHPS-type measures

Practical tips for fieldwork

  • Field HCP surveys over one to three weeks and keep them under 20 minutes. Physicians answer between clinics and in the evening.

  • Verify every professional respondent. Use panels that check licence or registration numbers, and add a knowledge screener.

  • Quota by specialty and setting (hospital versus private practice), because prescribing behavior differs sharply between them. Our sampling methods guide explains quota design.

  • Use small samples honestly. Fifty oncologists can be a strong study if the universe is 400. Report percentages with the base size and avoid false precision.

  • Translate clinically, not literally. Multi-country studies need medical translators and local terminology checks.

Deeper patient and HCP answers, with the guardrails in place

Healthcare studies need qualitative depth, why a physician switches, what a patient fears, at sample sizes qualitative teams struggle to reach.

SmartInterview runs AI-moderated interviews by voice or text, probing vague answers in the respondent's own language, then codes open answers into themes. The coded output makes it easier to review every passage that mentions side effects or identifiers before reporting. Keep your sponsor's adverse event procedure and privacy rules in charge: the tool speeds the review, it does not replace it.

Start free

Frequently Asked Questions

What is healthcare market research?

Healthcare market research is the systematic study of how patients, healthcare professionals, payers and providers make decisions about treatments, devices and services. It combines surveys, interviews, conjoint and tracking studies, under privacy rules for health data and, in pharma, adverse event reporting obligations.

What are the main types of healthcare market research?

The main types are patient journey research, awareness-trial-usage tracking with HCPs, message and concept testing, conjoint on treatment attributes, unmet-needs and KOL interviews, market access research with payers, and patient experience research for providers.

Is HIPAA required for market research surveys?

Only when identifiable health information comes from or is handled for a HIPAA covered entity or business associate, such as a hospital sharing patient data. A survey run by a brand directly with consenting panelists is usually outside HIPAA, but state privacy laws and GDPR may still apply, and health data always deserves strict protection.

What is adverse event reporting in market research?

It is the process of passing any mention of a side effect of a sponsor's product, raised by a respondent during research, to the sponsor's pharmacovigilance team. Industry codes such as EphMRA's and BHBIA's give guidance; procedures and timelines are agreed with the sponsor before fieldwork.

How do you recruit physicians for market research?

Most studies use specialized medical panels that verify licence or registration numbers, sometimes supplemented by list recruitment and referrals for rare specialties. Pay fair-market-value honoraria, keep surveys short, and allow one to three weeks of fieldwork.

How many physicians do you need for a healthcare survey?

It depends on the size of the specialty, not just on statistics. For a common specialty, 150 to 300 completes allow subgroup analysis; for rare specialties, 30 to 80 can represent a meaningful share of the whole population. Always report base sizes.

Table des matières

Articles associés

Inscrivez-vous gratuitement

Inscrivez-vous gratuitement

Inscrivez-vous gratuitement